Completed OBSERVATIONAL NCT04424173

Combined Hormone Therapy, C-reactive Protein(CRP) Levels and Life Quality in Natural Menopause Women

The Effect of Low Dose Combined Hormone Therapy (Estradiol And Norethindrone Acetate) on Serum CRP Levels and Life Quality in Natural Menopause Women

Sponsor: Karadeniz Technical University

Conditions CRP Menopause

Updated 4 times since 2020 Last updated: Jun 25, 2020 Started: Aug 1, 2007 Primary completion: Aug 1, 2008 Completion: Aug 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on CRP and Menopause, this trial is completed. The trial is conducted by Karadeniz Technical University and has accumulated 4 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jul 2020 — Jan 2021 [monthly]

Completed

First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Karadeniz Technical University

Data source: Karadeniz Technical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.